<DOC>
	<DOCNO>NCT00309530</DOCNO>
	<brief_summary>This clinical investigation examine effectivity 5-fluorouracil , add levamisol interferon 5-fluorouracil , 5-fluorouracil/levamisol/interferon triple combination , term recurrence-free overall survival curatively operable colon carcinoma Stage III .</brief_summary>
	<brief_title>Randomized Study Adjuvant Chemotherapy Adjuvant Chemo-Immunotherapy Colon Carcinoma Dukes C</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Patients histologically verify , curatively operate colon carcinoma Stage III ( R0 , T14 , N13 , M0 ) Age : less 80 year WHO Performace Status &gt; 2 Adequate bone marrow reserve Informed consent Rectal cancer R1 , R2 , carcinosis peritonei Start chemo chemoimmunotherapy &gt; 42 day postop ; adjuvant radiotherapy , chemotherapy immunotherapy Serious concomitant disease , particular chronically inflammatory large intestine , cardiopathic disease , malignant second carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 1999</verification_date>
	<keyword>Fluorouracil</keyword>
	<keyword>Levamisol</keyword>
	<keyword>Interferon</keyword>
	<keyword>Colon cancer</keyword>
</DOC>